CopA Protects Actinobacillus pleuropneumoniae against Copper Toxicity

被引:2
|
作者
Peng, Wei [1 ,4 ]
Yang, Xia [1 ,4 ]
Yan, Kang [1 ,4 ]
Chen, Huanchun [1 ,4 ]
Yuan, Fangyan [3 ]
Bei, Weicheng [1 ,2 ,4 ]
机构
[1] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China
[2] State Key Lab Genet Engn Vet Vaccines, Qingdao, Peoples R China
[3] Hubei Acad Agr Sci, Inst Anim Husb & Vet Sci, Minist Agr, Key Lab Prevent & Control Agents Anim Bacteriosis, Wuhan, Peoples R China
[4] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Peoples R China
关键词
Actinobacillus pleuropneumoniae; CopA; copper efflux; copper resistance; MYXOCOCCUS-XANTHUS; VIRULENCE; EFFLUX; IRON; PATHOGENESIS; TOLERANCE;
D O I
10.1016/j.vetmic.2021.109122
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Actinobacillus pleuropneumoniae is a Gram-negative bacterium causing porcine pleuropneumonia and severe economic losses in the global swine industry. The toxic trace element copper is required for many physiological and pathological processes in organisms. However, CopA, one of the most well-characterized P-type ATPases contributing to copper resistance, has not been characterized in A. pleuropneumoniae. We used quantitative PCR analysis to examine expression of the copA gene in A. pleuropneumoniae and investigated sequence conservation among serotypes and other Gram-negative bacteria. Growth characteristics were determined using growth curve analyses and spot dilution assays of the wild-type strain and a /copA mutant. We also used flame atomic absorption spectrophotometry to determine intracellular copper content and examined the virulence of the /copA mutant in a mouse model. The copA expression was induced by copper, and its nucleotide sequence was highly conserved among different serotypes of A. pleuropneumoniae. The amino acid sequence of CopA shared high identity with CopA sequences reported from several Gram-negative bacteria. Furthermore, the /copA mutant exhibited impaired growth and had higher intracellular copper content compared with the wild-type strain when supplemented with copper. The mouse model revealed that CopA had no influence on the virulence of A. pleuropneumoniae. In conclusion, these results demonstrated that CopA is required for resistance of A. pleuropneumoniae to copper and protects A. pleuropneumoniae against copper toxicity via copper efflux.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] CopA Protects Streptococcus suis against Copper Toxicity
    Zheng, Chengkun
    Jia, Mengdie
    Lu, Tianyu
    Gao, Miaomiao
    Li, Lingzhi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12):
  • [2] The antibacterial mechanism of berberine against Actinobacillus pleuropneumoniae
    Kang, Shuai
    Li, Zhengwen
    Yin, Zhongqiong
    Jia, Renyong
    Song, Xu
    Li, Li
    Chen, Zhenzhen
    Peng, Lianci
    Qu, Jing
    Hu, Zhiqiang
    Lai, Xin
    Wang, Guangxi
    Liang, Xiaoxia
    He, Changliang
    Yin, Lizi
    NATURAL PRODUCT RESEARCH, 2015, 29 (23) : 2203 - 2206
  • [3] New trends in innovative vaccine development against Actinobacillus pleuropneumoniae
    Loera-Muro, Abraham
    Angulo, Carlos
    VETERINARY MICROBIOLOGY, 2018, 217 : 66 - 75
  • [4] Actinobacillus pleuropneumoniae in swine
    Haesebrouck, F
    Castryck, F
    VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 1996, 65 (01): : 42 - 43
  • [5] Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice
    Meili Shao
    Yong Wang
    Chunlai Wang
    Yang Guo
    Yonggang Peng
    Jiandong Liu
    Guangxing Li
    Huifang Liu
    Siguo Liu
    Acta Veterinaria Scandinavica, 52
  • [6] In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae
    Antenucci, Fabio
    Fougeroux, Cyrielle
    Deeney, Alannah
    Orskov, Cathrine
    Rycroft, Andrew
    Holst, Peter Johannes
    Bojesen, Anders Miki
    VETERINARY RESEARCH, 2018, 49
  • [7] In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae
    Fabio Antenucci
    Cyrielle Fougeroux
    Alannah Deeney
    Cathrine Ørskov
    Andrew Rycroft
    Peter Johannes Holst
    Anders Miki Bojesen
    Veterinary Research, 49
  • [8] Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae
    Tanigawa, M
    Sawada, T
    JOURNAL OF VETERINARY MEDICINE SERIES B-INFECTIOUS DISEASES AND VETERINARY PUBLIC HEALTH, 2002, 49 (10): : 513 - 518
  • [9] FACTORS INVOLVED IN IMMUNITY AGAINST ACTINOBACILLUS-PLEUROPNEUMONIAE IN MICE
    BHATIA, B
    MITTAL, KR
    FREY, J
    VETERINARY MICROBIOLOGY, 1991, 29 (02) : 147 - 158
  • [10] Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice
    Shao, Meili
    Wang, Yong
    Wang, Chunlai
    Guo, Yang
    Peng, Yonggang
    Liu, Jiandong
    Li, Guangxing
    Liu, Huifang
    Liu, Siguo
    ACTA VETERINARIA SCANDINAVICA, 2010, 52